UK Markets open in 3 hrs 55 mins

Biotest Aktiengesellschaft (0N6Z.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
43.300.00 (0.00%)
At close: 05:21PM GMT
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 343.30
52-week low 343.10
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 539.57M
Implied shares outstanding 6N/A
Float 820.32M
% held by insiders 189.88%
% held by institutions 14.20%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.04
Trailing annual dividend yield 30.09%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -6.49%
Operating margin (ttm)-4.24%

Management effectiveness

Return on assets (ttm)-1.17%
Return on equity (ttm)-7.46%

Income statement

Revenue (ttm)507.2M
Revenue per share (ttm)12.84
Quarterly revenue growth (yoy)0.50%
Gross profit (ttm)130.1M
EBITDA 1.4M
Net income avi to common (ttm)-33.3M
Diluted EPS (ttm)-0.89
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)85.1M
Total cash per share (mrq)2.28
Total debt (mrq)498.6M
Total debt/equity (mrq)118.04
Current ratio (mrq)5.14
Book value per share (mrq)11.22

Cash flow statement

Operating cash flow (ttm)-5.5M
Levered free cash flow (ttm)-35.1M